Reporting pharmacoeconomic evaluations
- PMID: 16277544
- DOI: 10.2165/00019053-200523110-00001
Reporting pharmacoeconomic evaluations
Similar articles
-
Evaluating the quality of published pharmacoeconomic evaluations.Hosp Pharm. 1995 Feb;30(2):146-8, 151-2. Hosp Pharm. 1995. PMID: 10140528 No abstract available.
-
Pharmacoeconomic analyses: making them transparent, making them credible.JAMA. 2000 Apr 26;283(16):2158-60. doi: 10.1001/jama.283.16.2158. JAMA. 2000. PMID: 10791510 No abstract available.
-
[Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].Ned Tijdschr Geneeskd. 2010;154:A958. Ned Tijdschr Geneeskd. 2010. PMID: 20699045 Dutch.
-
[Methods for analyzing uncertainty].Farm Hosp. 2011 May;35 Suppl 2:3-9. doi: 10.1016/S1130-6343(11)70016-2. Farm Hosp. 2011. PMID: 22445503 Review. Spanish.
-
Reassessing the relevance of pharmacoeconomic analyses in formulary decisions.Pharmacoeconomics. 1998 May;13(5 Pt 1):479-85. doi: 10.2165/00019053-199813050-00001. Pharmacoeconomics. 1998. PMID: 10180747 Review. No abstract available.
Cited by
-
Meandering down the road to transparency.Pharmacoeconomics. 2008;26(3):179-80. doi: 10.2165/00019053-200826030-00001. Pharmacoeconomics. 2008. PMID: 18282012 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources